Buproprion, public funding, and smoking cessation.
Bloomfield
Ashley
A
D018687:Antidepressive Agents, Second-Generation / Q000191:economics* / Q000627:therapeutic use; D016642:Bupropion / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017277:Drug Approval; D006291:Health Policy; D006801:Humans; D009520:New Zealand; D016540:Smoking Cessation / Q000191:economics* / Q000379:methods; D014029:Tobacco Use Disorder / Q000188:drug therapy*
D018687:Antidepressive Agents, Second-Generation; D016642:Bupropion